menu close
www.om1.com
Om1 Inc-Logo

OM1 Stock

Company Profile:

OM1 is a healthcare technology company that specializes in transforming population data into actionable insights to improve patient outcomes.

Sign up for SecondMarket™ to view the market and buy or sell OM1 Stock
Buy + Sell

OM1 Funding

Sign up to gain insights into OM1 funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jul 01, 2021 Series D 85.00M
Price
Valuation
Oct 22, 2019 Series C 50.00M
Price
Valuation
May 22, 2018 Series B 21.00M
Price
Valuation
Jul 20, 2016 Series A 14.50M
Price
Valuation
Sep 25, 2015 Series Seed 1.25M
Price
Valuation
Sep 25, 2015 Series A 4.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

OM1 Management Team

  • Chief Medical Officer

    Gary Curhan

  • Director

    Larry Bohn

  • CTO

    Eric Schrock

  • Chief Operating Officer

    Robin Pepper

  • Founder, CEO

    Richard Gliklich

  • CFO

    Dennis Reilly

  • Director

    Gary Gottlieb

  • Director

    Dave Barrett

  • Director

    Rory O'Driscoll

OM1 Major Investors

  • Glikvest

  • 7wire Ventures

  • Kaiser Permanente Ventures

  • Breyer Capital

  • Scale Venture Partners

  • General Catalyst Partners LLC

  • D1 Capital Partners

  • Polaris Partners

Learn More About OM1 Stock

Buy OM1 Stock
01

OM1 stock does not trade on public stock exchanges. OM1 stock is considered a private security and you need to be an accredited investor to trade shares. To invest in OM1 stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell OM1 Stock
02

OM1 Stock does not trade on public stock exchanges. In order to sell OM1 shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

OM1 Stock Price
03

OM1 does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view OM1 share price and other valuable private market data.

Read more about secondary market private company stock prices:

OM1 Stock Ticker Symbol
04

There is no ticker symbol for OM1 stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell OM1 Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell OM1 stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in OM1 Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in OM1 stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

OM1 Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

OM1 IPO
08

OM1 is a private company and has not had an IPO. There is currently no OM1 IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to OM1 IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell OM1 Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Rakuten Medical-Logo

Rakuten Medical

Developing precision, cell-targeting investigational therapies on its Illuminox platform, which have shown rapid and selective cell killing and tumor necrosis in pre-clinical studies.

Nutcracker Therapeutics-Logo

Nutcracker Therapeutics

Uses high-technology engineering and advanced biosynthesis to advance mRNA therapeutics through strategic partnerships with clinical institutions and pharmaceutical/biotech companies.

Billiontoone-Logo

BillionToOne

Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

Source: Nasdaq Private Market Tape D™